Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: A gynecologic oncology group study

Journal of Clinical Oncology

Volumn 29, Issue 7, 2011, Pages 825-831

  Osborne, Raymond J ^a   Filiaci, Virginia ^a   Schink, Julian C ^a   Mannel, Robert S ^a   Secord, Angeles Alvarez ^a   Kelley, Joseph L ^a   Provencher, Diane ^a   Miller, David Scott ^a   Covens, Allan L ^a   Lage, Janice M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; METHOTREXATE;

ADOLESCENT; ADULT; ALLERGY; ALOPECIA; ANEMIA; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CANCER RECURRENCE; CARDIOTOXICITY; CHILD; CHORIOCARCINOMA; DIARRHEA; DRUG FEVER; DRUG TOLERABILITY; ENDOCRINE DISEASE; EYE TOXICITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION; LEUKOPENIA; LIVER TOXICITY; LUNG TOXICITY; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METASTASIS; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; NEUTROPENIA; PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; SCORING SYSTEM; SEXUAL DYSFUNCTION; SKIN TOXICITY; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; TROPHOBLASTIC TUMOR; UROGENITAL TRACT DISEASE; VOMITING; WORLD HEALTH ORGANIZATION;

ADULT; BIOPSY, NEEDLE; CHORIOCARCINOMA; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LOGISTIC MODELS; MAXIMUM TOLERATED DOSE; MEDICAL ONCOLOGY; METHOTREXATE; NEOPLASM STAGING; ODDS RATIO; ONTARIO; PREGNANCY; PULSE THERAPY, DRUG; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952335702     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.4386     Document Type: Article

References (25)

1. Rustin GJ, Newlands ES, Lutz JM, et al: Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 14:2769-2773, 1996 (Pubitemid 26329663)
2. Lurain JR, Elfstrand EP: Single-agent methotrexate chemotherapy for the treatment of non-metastatic trophoblastic tumors. Am J Obstet Gynecol 172:574-579, 1995
3. Roberts JP, Lurain JR: Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 174:1917-1923, 1996; discussion 1923-1924
4. Soper JT, Clarke-Pearson DL, Berchuck A, et al: 5-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 54:76-79, 1994
5. Elit L, Covens A, Osborne R, et al: High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol 54:282-287, 1994 (Pubitemid 24301901)
6. Wong LC, Ngan HY, Cheng DK, et al: Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol 183:1579-1582, 2000 (Pubitemid 32061228)
7. Petrilli ES, Twiggs LB, Blessing JA, et al: Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease: A prospective phase II trial of the Gynecologic Oncology Group. Cancer 60:2173-2176, 1987 (Pubitemid 17153478)
8. Kohorn EI: Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance? Gynecol Oncol 85:36-39, 2002
9. Osathanondh R, Goldstein DP, Pastorfide GB: Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer 36:863-866, 1975
10. Twiggs LB: Pulse actinomycin D scheduling in non-metastatic gestational trophoblastic disease. Gynecol Oncol 16:190-195, 1983
11. Smith EB, Weed JC Jr, Tyrey L, et al: Treatment of nonmetastatic gestational trophoblastic disease: Results of methotrexate alone versus methotrexate-folinic acid. Am J Obstet Gynecol 144:88-92, 1982 (Pubitemid 12054362)
12. Homesley HD, Blessing JA, Rettenmaier M, et al: Weekly intramuscular methotrexate for non-metastatic gestational trophoblastic disease. Obstet Gynecol 72:413-418, 1988
13. Homesley HD, Blessing JA, Schlaerth J, et al: Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: A Gynecologic Oncology Group study. Gynecol Oncol 39:305-308, 1990
14. Schlaerth JB, Morrow CP, Nalick RH, et al: Single-dose actinomycin D in the treatment of postmolar trophoblastic disease. Gynecol Oncol 19:53-56, 1984 (Pubitemid 14027477)
15. Kohorn EI: Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia: A progress report. J Reprod Med 47:445-450, 2002
16. Hancock B, Okines A: An evaluation of FIGO 2000: The first 5 years. Proceedings of the XIV World Congress of the ISSTD, Fukuoka, Japan, November 2007
17. Casagrande JT, Pike MC, Smith PG: The power function of the "exact" test for comparing two binomial distributions. J R Stat Soc C 27:176-180, 1978
18. DeMets DL, Lan G: The alpha spending function approach to interim data analyses. Cancer Treat Res 75:1-27, 1995
19. McGrath S, Savage P, Seckl M: Management and outcome of women with post hydatidiform mole and low risk GTN with hCG levels in excess of 100,000 IU/L. Proceedings of the XV World Congress on GTD, Cochin, India, November 2009
20. Osborne RJ, Filiaci V, Schink J, et al: Systematic risk score assignment errors in patients with gestational trophoblastic neoplasia. Proceedings of the XIII World Congress of the ISSTD, Hong Kong, November 2005
21. Kohorn EI: Gestational trophoblastic neoplasia and evidence-based medicine. J Reprod Med 47:427-432, 2002
22. Elit L, Gafni A, Levine MN. Better treatments that cost more: The dilemma. Gynecol Oncol 78:1-2, 2000 (Pubitemid 30439468)
23. Bagshawe KD, Dent J, Newlands ES, et al: The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 96:795-799, 1989
24. McNeish IA, Strickland S, Holden L, et al: Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2002. J Clin Oncol 20:1838-1844, 2002
25. Chapman-Davis E, Lurain J. Management of low-risk GTN. Proceedings of the XV World Congress on GTD, Cochin, India, November 2009